GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Wesleyan Assurance Society

Wesleyan Assurance Society cut its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 8,732 shares of the company’s stock after selling 416 shares during the period. Wesleyan Assurance Society’s holdings in GE HealthCare Technologies were worth $680,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of GEHC. International Assets Investment Management LLC lifted its holdings in shares of GE HealthCare Technologies by 6.8% during the 4th quarter. International Assets Investment Management LLC now owns 7,828 shares of the company’s stock valued at $605,000 after acquiring an additional 499 shares in the last quarter. J.W. Cole Advisors Inc. lifted its stake in shares of GE HealthCare Technologies by 7.3% during the fourth quarter. J.W. Cole Advisors Inc. now owns 4,437 shares of the company’s stock worth $343,000 after purchasing an additional 302 shares in the last quarter. abrdn plc boosted its position in shares of GE HealthCare Technologies by 72.9% in the fourth quarter. abrdn plc now owns 163,720 shares of the company’s stock worth $12,659,000 after buying an additional 69,054 shares during the period. Lindbrook Capital LLC grew its stake in shares of GE HealthCare Technologies by 52.6% in the fourth quarter. Lindbrook Capital LLC now owns 2,141 shares of the company’s stock valued at $166,000 after buying an additional 738 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in shares of GE HealthCare Technologies by 16.2% during the 4th quarter. Signaturefd LLC now owns 4,323 shares of the company’s stock valued at $334,000 after buying an additional 603 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Analyst Ratings Changes

GEHC has been the subject of a number of analyst reports. Stifel Nicolaus assumed coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target for the company. Mizuho decreased their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Bank of America reduced their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $95.00.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $0.41 during mid-day trading on Friday, hitting $84.78. 1,511,760 shares of the company’s stock traded hands, compared to its average volume of 3,015,838. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a market cap of $38.70 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17. The firm has a 50 day moving average price of $80.77 and a 200 day moving average price of $83.40. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.02. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.92 earnings per share. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.